Literature DB >> 23845910

Optimal variable flip angle schemes for dynamic acquisition of exchanging hyperpolarized substrates.

Yan Xing1, Galen D Reed, John M Pauly, Adam B Kerr, Peder E Z Larson.   

Abstract

In metabolic MRI with hyperpolarized contrast agents, the signal levels vary over time due to T1 decay, T2 decay following RF excitations, and metabolic conversion. Efficient usage of the nonrenewable hyperpolarized magnetization requires specialized RF pulse schemes. In this work, we introduce two novel variable flip angle schemes for dynamic hyperpolarized MRI in which the flip angle is varied between excitations and between metabolites. These were optimized to distribute the magnetization relatively evenly throughout the acquisition by accounting for T1 decay, prior RF excitations, and metabolic conversion. Simulation results are presented to confirm the flip angle designs and evaluate the variability of signal dynamics across typical ranges of T1 and metabolic conversion. They were implemented using multiband spectral-spatial RF pulses to independently modulate the flip angle at various chemical shift frequencies. With these schemes we observed increased SNR of [1-(13)C]lactate generated from [1-(13)C]pyruvate, particularly at later time points. This will allow for improved characterization of tissue perfusion and metabolic profiles in dynamic hyperpolarized MRI.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamic MRSI; Hyperpolarized carbon-13; Multi-band RF pulse; RF pulse design; Variable flip angle

Mesh:

Substances:

Year:  2013        PMID: 23845910      PMCID: PMC3765634          DOI: 10.1016/j.jmr.2013.06.003

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  32 in total

1.  Transient decrease in tumor oxygenation after intravenous administration of pyruvate.

Authors:  Keita Saito; Shingo Matsumoto; Nallathamby Devasahayam; Sankaran Subramanian; Jeeva P Munasinghe; H Douglas Morris; Martin J Lizak; Jan Henrik Ardenkjaer-Larsen; James B Mitchell; Murali C Krishna
Journal:  Magn Reson Med       Date:  2011-10-17       Impact factor: 4.668

2.  Gradient-Echo Imaging Considerations for Hyperpolarized 129Xe MR

Authors: 
Journal:  J Magn Reson B       Date:  1996-11

3.  Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice.

Authors:  Matthew L Zierhut; Yi-Fen Yen; Albert P Chen; Robert Bok; Mark J Albers; Vickie Zhang; Jim Tropp; Ilwoo Park; Daniel B Vigneron; John Kurhanewicz; Ralph E Hurd; Sarah J Nelson
Journal:  J Magn Reson       Date:  2009-10-13       Impact factor: 2.229

4.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.

Authors:  Simon Hu; Asha Balakrishnan; Robert A Bok; Brittany Anderton; Peder E Z Larson; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Andrei Goga
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

5.  Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS.

Authors:  Christine Leon Swisher; Peder E Z Larson; Klaus Kruttwig; Adam B Kerr; Simon Hu; Robert A Bok; Andrei Goga; John M Pauly; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2013-02-14       Impact factor: 4.668

6.  Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR.

Authors:  Crystal Harrison; Chendong Yang; Ashish Jindal; Ralph J DeBerardinis; M A Hooshyar; Matthew Merritt; A Dean Sherry; Craig R Malloy
Journal:  NMR Biomed       Date:  2012-03-26       Impact factor: 4.044

7.  Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies.

Authors:  Peder E Z Larson; Simon Hu; Michael Lustig; Adam B Kerr; Sarah J Nelson; John Kurhanewicz; John M Pauly; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2010-10-11       Impact factor: 4.668

8.  Detection of inflammatory arthritis by using hyperpolarized 13C-pyruvate with MR imaging and spectroscopy.

Authors:  John D MacKenzie; Yi-Fen Yen; Dirk Mayer; James S Tropp; Ralph E Hurd; Daniel M Spielman
Journal:  Radiology       Date:  2011-03-15       Impact factor: 11.105

9.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

10.  Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C.

Authors:  Charles H Cunningham; Albert P Chen; Mark J Albers; John Kurhanewicz; Ralph E Hurd; Yi-Fen Yen; John M Pauly; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson       Date:  2007-06-02       Impact factor: 2.229

View more
  29 in total

1.  A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS.

Authors:  Christopher M Walker; Yunyun Chen; Stephen Y Lai; James A Bankson
Journal:  Med Phys       Date:  2016-02       Impact factor: 4.071

2.  Non-invasive in vivo assessment of IDH1 mutational status in glioma.

Authors:  Myriam M Chaumeil; Peder E Z Larson; Hikari A I Yoshihara; Olivia M Danforth; Daniel B Vigneron; Sarah J Nelson; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Optimizing Flip Angles for Metabolic Rate Estimation in Hyperpolarized Carbon-13 MRI.

Authors:  John Maidens; Jeremy W Gordon; Murat Arcak; Peder E Z Larson
Journal:  IEEE Trans Med Imaging       Date:  2016-05-27       Impact factor: 10.048

Review 4.  The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.

Authors:  Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi
Journal:  Adv Drug Deliv Rev       Date:  2016-09-04       Impact factor: 15.470

Review 5.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

6.  Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer.

Authors:  Hsin-Yu Chen; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; Marcus Ferrone; Mark van Criekinge; Lucas Carvajal; Peng Cao; John M Pauly; Adam B Kerr; Ilwoo Park; James B Slater; Sarah J Nelson; Pamela N Munster; Rahul Aggarwal; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

7.  Kinetic Modeling of Hyperpolarized Carbon-13 Pyruvate Metabolism in the Human Brain.

Authors:  Daniele Mammoli; Jeremy Gordon; Adam Autry; Peder E Z Larson; Yan Li; Hsin-Yu Chen; Brian Chung; Peter Shin; Mark Van Criekinge; Lucas Carvajal; James B Slater; Robert Bok; Jason Crane; Duan Xu; Susan Chang; Daniel B Vigneron
Journal:  IEEE Trans Med Imaging       Date:  2019-07-02       Impact factor: 10.048

8.  Simultaneous imaging of 13C metabolism and 1H structure: technical considerations and potential applications.

Authors:  Jeremy W Gordon; Sean B Fain; David J Niles; Kai D Ludwig; Kevin M Johnson; Eric T Peterson
Journal:  NMR Biomed       Date:  2015-03-25       Impact factor: 4.044

9.  A regional bolus tracking and real-time B1 calibration method for hyperpolarized 13 C MRI.

Authors:  Shuyu Tang; Eugene Milshteyn; Galen Reed; Jeremy Gordon; Robert Bok; Xucheng Zhu; Zihan Zhu; Daniel B Vigneron; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2018-09-18       Impact factor: 4.668

10.  High spatiotemporal resolution bSSFP imaging of hyperpolarized [1-13 C]pyruvate and [1-13 C]lactate with spectral suppression of alanine and pyruvate-hydrate.

Authors:  Eugene Milshteyn; Cornelius von Morze; Jeremy W Gordon; Zihan Zhu; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-02-16       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.